(Q44444364)

3 December 2017

title

Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice (English)

1 reference

3 December 2017

Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

3 January 2024

1 reference

1 reference

1 reference

aortic atherosclerosis

1 reference

Neal Azrolan

2

1 reference

3 December 2017

Pa-Lang Hsu

4

1 reference

3 December 2017

M. Merle Elloso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752312

3 January 2024

Suren N. Sehgal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752312

3 January 2024

Kristen L. Phiel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752312

3 January 2024

Caroline A. Kopec

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752312

3 January 2024

Michael D. Basso

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752312

3 January 2024

Steven J. Adelman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752312

3 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-6143.2003.00094.x

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

https://api.elsevier.com/content/article/PII:S1600613522072975?httpAccept=text/xml

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

https://api.elsevier.com/content/article/PII:S1600613522072975?httpAccept=text/plain

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-6143.2003.00094.x/fullpdf

3 January 2024

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

American Journal of Transplantation

3 January 2024

published in

1 reference

3 December 2017

volume

3

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

562-569

1 reference

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Rapamycin resistance tied to defective regulation of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Lymphocytes are important in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Stimulation of transforming growth factor-beta 1 transcription by cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

Expression of Interleukin-10 in Advanced Human Atherosclerotic Plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Rapamycin: a novel immunosuppressive macrolide

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Quantitative assessment of atherosclerotic lesions in mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Rapamycin induces transforming growth factor-beta production by lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Adjunctive rapamycin and CsA treatment inhibits monocyte/macrophage associated cytokines/chemokines in sensitized cardiac graft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Production of transforming growth factor beta 1 during repair of arterial injury

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Proliferation of human smooth muscle cells promoted by lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

A pivotal role for TGF-beta in atherogenesis?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00094.X

7 January 2021

Detection of activated T lymphocytes in the human atherosclerotic plaque

6

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques

3 January 2024

8

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice

3 January 2024

28

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

Cardiac transplant atherosclerosis

3 January 2024

66

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

Graft coronary disease: the lesions and the patients

3 January 2024

67

1 reference

https://api.crossref.org/works/10.1034/J.1600-6143.2003.00094.X

3 January 2024

Identifiers

1 reference

3 December 2017

1 reference